 |
0 Diseases |  |
30 Trials |
|
30 Trials |  |
4896 News |  |
| «12...64656667686970717273747576» |
- | Enrollment change, Trial termination, Trial primary completion date, Adverse events: Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) - Oct 19, 2017
P3, N=407, Terminated, Sponsor: Hannover Medical School
N=2000 --> 407 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> Jun 2017
- | lithium carbonate ER / Generic mfg.
Enrollment open, Enrollment change, HEOR: Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=1300000, Enrolling by invitation, Sponsor: University of New Mexico
N=2000 --> 407 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> Jun 2017 Not yet recruiting --> Enrolling by invitation | N=1000000 --> 1300000
- | topiramate / Generic mfg., carbamazepine / Generic mfg.
New P4 trial: Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy (clinicaltrials.gov) - Oct 11, 2017
P4, N=69, Recruiting, Sponsor: University of Sao Paulo
- | carbamazepine / Generic mfg.
Enrollment change, Adverse drug reaction: Pathogenesis of Adverse Drug Reactions (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=274, Completed, Sponsor: Children's Mercy Hospital Kansas City
Not yet recruiting --> Enrolling by invitation | N=1000000 --> 1300000 N=98 --> 274
- | Enrollment open, Adverse events: BEEP2b: Characterization of Epilepsy Patients BEEP 2b (clinicaltrials.gov) - Aug 3, 2017
P4, N=12, Enrolling by invitation, Sponsor: Food and Drug Administration (FDA)
N=98 --> 274 Not yet recruiting --> Enrolling by invitation
- | Fycompa (perampanel) / Eisai, Catalyst Pharma, Ospolot (sultiam) / AOP Orphan Pharma, Diacomit (stiripentol) / Biocodex, Meiji Seika
Enrollment open: EPIPOP: Population Pharmacokinetics of Antiepileptic in Pediatrics (clinicaltrials.gov) - Jul 4, 2017
P=N/A, N=1000, Recruiting, Sponsor: Assistance Publique - H
Not yet recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- | Fycompa (perampanel) / Eisai, Catalyst Pharma, Ospolot (sultiam) / AOP Orphan Pharma, Diacomit (stiripentol) / Biocodex, Meiji Seika
New trial: EPIPOP: Population Pharmacokinetics of Antiepileptic in Pediatrics (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=1000, Not yet recruiting, Sponsor: Assistance Publique - H
- | paracetamol / Generic mfg.
New P4 trial: Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy (clinicaltrials.gov) - May 18, 2017
P4, N=50, Not yet recruiting, Sponsor: Rambam Health Care Campus
- carbamazepine / Generic mfg.
Trial primary completion date: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency (clinicaltrials.gov) - May 11, 2017
P2, N=30, Recruiting, Sponsor: Washington University School of Medicine
Not yet recruiting --> Recruiting Trial primary completion date: Jan 2017 --> Jan 2019
- | Phase classification, Trial initiation date, Adverse events: BEEP2b: Characterization of Epilepsy Patients BEEP 2b (clinicaltrials.gov) - May 8, 2017
P4, N=12, Not yet recruiting, Sponsor: Food and Drug Administration (FDA)
Trial primary completion date: Jan 2017 --> Jan 2019 Phase classification: P=N/A --> P4 | Initiation date: Apr 2017 --> Jul 2017
- | Nitredon (nitrazepam) / Remedica, Diacomit (stiripentol) / Biocodex, Meiji Seika
Trial primary completion date: Ketogenic Diet in Infants With Epilepsy (KIWE) (clinicaltrials.gov) - May 3, 2017
P4, N=160, Recruiting, Sponsor: University College, London
Phase classification: P=N/A --> P4 | Initiation date: Apr 2017 --> Jul 2017 Trial primary completion date: Jan 2018 --> Jun 2018
- | carbamazepine / Generic mfg., oxcarbazepine / Generic mfg.
Trial completion, Enrollment change: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures (clinicaltrials.gov) - Mar 29, 2017
P4, N=90, Completed, Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Trial primary completion date: Jan 2018 --> Jun 2018 Recruiting --> Completed | N=75 --> 90
- | Trial initiation date, Trial primary completion date, Adverse events: BEEP2b: Characterization of Epilepsy Patients BEEP 2b (clinicaltrials.gov) - Feb 28, 2017
P=N/A, N=12, Not yet recruiting, Sponsor: Food and Drug Administration (FDA)
Recruiting --> Completed | N=75 --> 90 Initiation date: Mar 2016 --> Apr 2017 | Trial primary completion date: Dec 2016 --> Dec 2017
- ||||||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
Trial completion, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Jan 12, 2017
P3, N=551, Completed, Sponsor: UCB BIOSCIENCES GmbH
Initiation date: Mar 2016 --> Apr 2017 | Trial primary completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Completed
- | desipramine / Generic mfg., carbamazepine / Generic mfg.
Trial completion: Pharmacotherapy and Intensive Treatment - 2 (clinicaltrials.gov) - Jan 11, 2017
P4, N=353, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Aptiom (eslicarbazepine) / Sumitomo Dainippon, BIAL
New P4 trial: Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults (clinicaltrials.gov) - Sep 22, 2016
P4, N=46, Recruiting, Sponsor: Stanford University
- lithium carbonate ER / Generic mfg.
New trial, HEOR: Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=1000000, Not yet recruiting, Sponsor: University of New Mexico
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
Trial primary completion date, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - May 10, 2016
P3, N=551, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
No longer recruiting --> Completed Trial primary completion date: Mar 2016 --> Dec 2016
- Nitredon (nitrazepam) / Remedica, Diacomit (stiripentol) / Biocodex, Meiji Seika
Enrollment open, Trial primary completion date: Ketogenic Diet in Infants With Epilepsy (KIWE) (clinicaltrials.gov) - Apr 28, 2016
P4, N=160, Recruiting, Sponsor: University College, London
Trial primary completion date: Mar 2016 --> Dec 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Jan 2018
- carbamazepine / Generic mfg., oxcarbazepine / Generic mfg.
Enrollment open: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures (clinicaltrials.gov) - Apr 20, 2016
P4, N=75, Recruiting, Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Jan 2018 Not yet recruiting --> Recruiting
- New trial, Adverse events: BEEP2b: Characterization of Epilepsy Patients BEEP 2b (clinicaltrials.gov) - Mar 14, 2016
P=N/A, N=12, Not yet recruiting, Sponsor: Food and Drug Administration (FDA)
- | carbamazepine / Generic mfg., oxcarbazepine / Generic mfg.
New P4 trial: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures (clinicaltrials.gov) - Mar 11, 2016
P4, N=75, Not yet recruiting, Sponsor: All India Institute of Medical Sciences, Bhubaneswar
- |||| carbamazepine ER capsule / Generic mfg.
Enrollment open: DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder (clinicaltrials.gov) - Jan 11, 2016
P4, N=150, Recruiting, Sponsor: Validus Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| carbamazepine ER capsule / Generic mfg.
New P4 trial: DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder (clinicaltrials.gov) - Dec 5, 2015
P4, N=150, Not yet recruiting, Sponsor: Validus Pharmaceuticals
- ||||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Trial completion, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Oct 9, 2015
P3, N=436, Completed, Sponsor: UCB Pharma SA
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
Enrollment closed, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Aug 28, 2015
P3, N=551, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial completion, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Aug 27, 2015
P3, N=888, Completed, Sponsor: UCB BIOSCIENCES GmbH
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
Trial primary completion date, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Aug 13, 2015
P3, N=527, Recruiting, Sponsor: UCB BIOSCIENCES GmbH
Active, not recruiting --> Completed Trial primary completion date: Jul 2015 --> Mar 2016
- carbamazepine / Generic mfg.
Trial primary completion date: Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations (clinicaltrials.gov) - Jul 15, 2015
P4, N=2, Enrolling by invitation, Sponsor: VA Connecticut Healthcare System
Trial primary completion date: Jul 2015 --> Mar 2016 Trial primary completion date: Jun 2015 --> Dec 2015
- | citalopram / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram (clinicaltrials.gov) - Jun 24, 2015
P2/3, N=120, Completed, Sponsor: Tufts Medical Center
Trial primary completion date: Jun 2015 --> Dec 2015 Active, not recruiting --> Completed | N=150 --> 120 | Trial primary completion date: Oct 2013 --> Jul 2014
- carbamazepine / Generic mfg.
Trial primary completion date: Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations (clinicaltrials.gov) - Jun 11, 2015
P4, N=2, Enrolling by invitation, Sponsor: VA Connecticut Healthcare System
Active, not recruiting --> Completed | N=150 --> 120 | Trial primary completion date: Oct 2013 --> Jul 2014 Trial primary completion date: Dec 2014 --> Jun 2015
- |||| carbamazepine / Generic mfg.
Trial completion, Monotherapy: The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy (clinicaltrials.gov) - May 29, 2015
P4, N=207, Completed, Sponsor: Yonsei University
Trial primary completion date: Dec 2014 --> Jun 2015 Recruiting --> Completed
- carbamazepine / Generic mfg., oxcarbazepine / Generic mfg.
Trial completion: Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine. (clinicaltrials.gov) - Apr 22, 2015
P4, N=10, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Enrollment closed, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Mar 31, 2015
P3, N=436, Active, not recruiting, Sponsor: UCB Pharma SA
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial primary completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Mar 9, 2015
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2015 --> Jul 2015
- |||||||||| New P3 trial, Adverse events: Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) - Mar 2, 2015
P3, N=2000, Recruiting, Sponsor: Hannover Medical School
- carbamazepine / Generic mfg.
Trial primary completion date: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency (clinicaltrials.gov) - Dec 7, 2014
P2, N=30, Recruiting, Sponsor: University of Pittsburgh
Trial primary completion date: Feb 2015 --> Jul 2015 Trial primary completion date: Jan 2014 --> Jan 2017
- | Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
New P1 trial: Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine (clinicaltrials.gov) - Nov 6, 2014
P1, N=43, Completed, Sponsor: Bial - Portela C S.A.
- | Aptivus (tipranavir) / Boehringer Ingelheim
New P1 trial: Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers (clinicaltrials.gov) - Oct 2, 2014
P1, N=28, Completed, Sponsor: Boehringer Ingelheim
- carbamazepine / Generic mfg.
New P4 trial: Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations (clinicaltrials.gov) - Aug 12, 2014
P4, N=2, Enrolling by invitation, Sponsor: VA Connecticut Healthcare System
- | levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P4 trial, Monotherapy: The Effects on Cognitive Function of Levetiracetam (Keppra (clinicaltrials.gov) - Aug 5, 2014
P4, N=75, Completed, Sponsor: Yonsei University
- | Nitredon (nitrazepam) / Remedica, Diacomit (stiripentol) / Biocodex, Meiji Seika
New P4 trial: Ketogenic Diet in Infants With Epilepsy (KIWE) (clinicaltrials.gov) - Aug 1, 2014
P4, N=160, Not yet recruiting, Sponsor: University College, London
- carbamazepine / Generic mfg.
Trial completion: Fed Bioequivalence Study of CBZ Formulations (clinicaltrials.gov) - Jun 18, 2014
P1, N=20, Completed, Sponsor: Center for Clinical Pharmacology Research Bdbeq S.A.
Trial primary completion date: Jan 2014 --> Jan 2017 Recruiting --> Completed
- carbamazepine / Generic mfg.
New P1 trial: Fed Bioequivalence Study of CBZ Formulations (clinicaltrials.gov) - May 5, 2014
P1, N=20, Recruiting, Sponsor: Center for Clinical Pharmacology Research Bdbeq S.A.
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial primary completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Nov 2014
- ||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial primary completion date: Jan 2015 --> Nov 2014 Trial completion date: Jul 2015 --> Apr 2015
- ||||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Enrollment closed, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial completion date: Jul 2015 --> Apr 2015 Recruiting --> Active, not recruiting
- ||| carbamazepine / Generic mfg.
Enrollment change: The Young Adult and Pediatric Bipolar Study (clinicaltrials.gov) - Feb 18, 2014
P4, N=161, Completed, Sponsor: Validus Pharmaceuticals
Recruiting --> Active, not recruiting N=225 --> 161
- carbamazepine / Generic mfg.
Trial completion: Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=74, Completed, Sponsor: Carolinas Healthcare System
N=225 --> 161 Active, not recruiting --> Completed
- || lacosamide / Generic mfg.
Enrollment change: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Jan 22, 2014
P1, N=60, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed N=50 --> 60